Ypsomed Holding AG

Ypsomed Holding AG

World Rank (Aug-2026)
2965
Market Cap (Aug-2026)
6.640 Billion USD
World Rank (Jan-05-2024)
3,045
Market Cap (Jan-05-2024)
4.753 Billion USD
World Rank (Jul-30-2023)
3,500
Market Cap (Jul-30-2023)
4.038 Billion USD
World Rank (Jan-07-2022)
5,468
Market Cap (Jan-07-2022)
2.505 Billion USD
World Rank (Jan-01-2021)
5,316
Market Cap (Jan-01-2021)
2.091 Billion USD
Headquarters Country
Switzerland
Top Healthcare Companies in Europe
World Region
Europe
World Subregion
Western Europe
Annual Revenue in USD
927 Million USD
Annual Operating Income in USD
312 Million USD
Annual Net Income in USD
281 Million USD
Annual Results for Period Ending
For year ending March-2026
Total Assets in USD
1,708 Million USD
Total Liabilities in USD
759 Million USD
Total Equity in USD
949 Million USD
Balance Sheet for Period Ending
As of March-2026
Business Sector
Healthcare
Medical Equipment / Instruments
Company Website
YPSOMED HOLDING AG
Yahoo
Yahoo @ Switzerland
Company Profile
Ypsomed Holding AG is the leading developer and manufacturer of injection and infusion systems company for self medication and a renowned diabetes specialist. It is having around 1,900 employees worldwide. The company annual revenue is 403.6 million CHF, annual net income is 5.8 million CHF and total assets are 717.6 million CHF as on 2021. The headquarters is in Switzerland.
Founded Year
2003
Stock Exchange
Switzerland

Share